For people living with unresolved pain, it’s more than just physical. The consequences can permeate one’s entire life. The ability to function, the capacity to work, the opportunity to live with dignity – all can be compromised.
We believe pain should not define someone’s life. We believe we must do better.
At Lilly, we are sparking a new conversation about unresolved pain – a conversation that challenges us to tackle the uniquely complex scientific and societal challenges of recurrent and chronic pain, including migraine, episodic cluster headache and osteoarthritis pain. To do so, we are committed to advancing innovative science, policies and non-opioid medicines that are needed to reshape and enable a better approach to comprehensive pain management and treatment outcomes.
Our motivation is to redefine what’s possible for people living with acute and chronic pain – to help them live without compromise. With new science comes new hope, and with new hope comes new expectations.
Patrik JonssonSenior Vice President and President, Lilly Bio-Medicines